Aspen Pharmacare

Aspen’s Injectable Products segment covers anaesthetics, anticoagulants, and analgesics, with key brands including Arixtra, Diprivan, and Fraxiparine.

Aspen’s Manufacturing segment operates 24 facilities across 15 sites, producing steriles, liquids, and APIs with global regulatory accreditation.

Business Segment Over the counter Products that do not require a prescription and are mainly sold through retail pharmacies and the fast moving consumer goods sector, where brand recognition, marketing, and interactions with pharmacists play a key role in influencing consumer choices. Overview Key Brands Revenue Performance Emla Maltofer Magnesia Bisurada Mybulen Ovestin Solpadeine Xylocaine Topicals Topicalanaesthetic Ironsupplement Antacid Analgesic antiinflammatory Hormonereplacementtherapy O

Business Segment Prescription Products which generally require a prescription from a healthcare professional. Primary therapeutic areas are anti-inflammatories, immunosuppressants, hypothyroidism, anti-gout, analgesics, and corticosteroids. Overview Key Brands Revenue Performance Eltroxin Imuran Lipitor Lyrica Meticorten Purinethol Thyroid hormone Immunosuppressant Cardiovascular Anticonvulsantand neuropathy Corticosteroid Oncology Revenue by segment (%) 25% of Group revenue 36% of Group gross p

Aspen offers bursaries to qualifying South African citizens and children of Aspen South Africa employees pursuing approved qualifications.

With a 170-year heritage, Aspen is a global specialty & branded pharmaceutical company with a presence in emerging & developed markets.

Aspen’s Board of Directors is committed that the Group adheres to high standards of corporate governance in the conduct of its business.

Aspen operates 23 manufacturing facilities across 15 sites, many of which hold international accreditation.

Aspen is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets